Medical Advocates
HIV Infection/Disease
  Brain Disorders
General Reports                Oncology       
Diagnostics                        Seizures/Epilepsy                 
 Brain Abscesses                Cryptococcal Meningitis             
Brain Atrophy                    Cerebral Histoplasmosis                
Brain Lesions                    Cerebral Toxoplasmosis              
Brain Lymphoma              Dementia          
Encephalopathy                HIV/Psychiatric: General
Encephalitis                      Perception Disorders
Cerebral Lymphocytosis
 Cognitive Impairment
 Leukoencephalopathy
 Memory Disorders
 Movement Disorders      




 
CNS Main Page Main New/Newsworthy Home Page

Last Update: November 01, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
           Journal Papers, Abstracts, and Commentaries
 
 
Neurocognitive disturbances in HIV.
 Grant I.   
 Int Rev Psychiatry. 2008 Feb;20(1):33-47.
 Abstract
 
Co-factors in HIV neurobehavioural disturbances: Substance abuse, hepatitis C and aging.
 Gonzalez R, Cherner M.
 Int Rev Psychiatry. 2008 Feb;20(1):49-60.
 Abstract
 
Antiretroviral Treatment is Associated with Increased Attentional Load-Dependent Brain
Activation in HIV Patients.
Chang L, Yakupov R, Nakama H,, et al
J Neuroimmune Pharmacol. 2007 Oct 13
 Abstract

Biomarkers for neuroAIDS: the widening scope of metabolomics.
 Pendyala G, Want EJ, Webb W, et al  
 J Neuroimmune Pharmacol. 2007 Mar;2(1):72-80.
Abstract
 
The effects of illicit drugs on the HIV infected brain.
Anthony IC, Arango JC, Stephens B,et al 
Front Biosci. 2008 Jan 1;13:1294-307.
 Abstract
 
Memory performance in HIV/AIDS--a prospective case control study.
Odiase FE, Ogunrin OA, Ogunniyi AA.
Can J Neurol Sci. 2007 May;34(2):154-9.
 Abstract
 
Coma as a presenting symptom of primary HIV infection.
Umgelter A, Huber W, Schmid RM, Reindl W.
Sex Transm Infect. 2007 Apr;83(2):85-6.
 Abstract
 
Cerebral Aneurysmal Arteriopathy Associated with HIV Infection in an Adult.
Ake JA, Erickson JC, Lowry KJ. et al, et al    
Clin Infect Dis. 2006 Sep 1;43(5):e46-e50
 Abstract
 
The Blood-Brain Barrier in NeuroAIDS.
 Banks WA, Ercal N, Price TO.
 Curr HIV Res. 2006 Jul;4(3):259-66.
Abstract
 
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
Cysique LA, Maruff P, Brew BJ.
Neurology. 2006 May 9;66(9):1447-50.
 Abstract
 
Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use
illicit drugs.
Bell JE, Arango JC, Anthony IC.
J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91.
Abstract
 
Diffusion Alterations in Corpus Callosum of Patients with HIV.
Wu Y, Storey P, Cohen BA, Epstein LG, et al  
AJNR Am J Neuroradiol. 2006  Mar;27(3):656-60.
 Abstract
 
HIV disorders of the brain: pathology and pathogenesis.
Del Valle L, Pina-Oviedo S.
Front Biosci. 2006 Jan 1;11:718-32.
 Abstract
 
ASPD Blunts the Effects of HIV and Antiretroviral Treatment on Event-Related Brain Potentials.
Bauer LO, Shanley JD.
 Neuropsychobiology. 2005 Nov 24;53(1):17-25
Abstract
 
HIV disorders of the brain; pathology and pathogenesis.
Del Valle L, Pina-Oviedo S. et al
 Front Biosci. 2006 Jan 1;11:718-32.
 Abstract
 
The blood brain barrier in HIV infection.
Berger JR, Avison M.
Front Biosci. 2004 Sep 1;9:141-6.
 Abstract

Independent Evolution of Human Immunodeficiency Virus (HIV) Drug Resistance
Mutations in Diverse Areas of the Brain in HIV-Infected Patients, with and without
Dementia, on Antiretroviral Treatment.
Smit TK, Brew BJ, Tourtellotte W, et al.
 J Virol. 2004 Sep;78(18):10133-48
 Abstract
 
Cardio- and cerebrovascular events in HIV-infected persons.
The Writing Committee 
AIDS. 2004 Sep 3;18(13):1811-1817.
 Abstract

Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration
induced by HAART.
Miller RF, Isaacson PG, Hall-Craggs M ,et al.  
Acta Neuropathol (Berl). 2004 Apr 14
 Abstract
Diagnostics
 
           Journal Papers, Abstracts, and Commentaries
 
 
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance
imaging to cognitive function among nondemented individuals infected with HIV.
Paul RH, Ernst T, Brickman AM, et al
 J Int Neuropsychol Soc. 2008 Sep;14(5):725-33.
 Abstract
 
Neuroimaging in the Brain in HIV-1-Infected Patients.
Thurnher MM, Donovan Post MJ.
Neuroimaging Clin N Am. 2008 Feb;18(1):93-117.
 Abstract
 
Magnetic Resonance Imaging Findings of the Brain in Adult HIV and AIDS Patients.
Kloska SP, Husstedt IW, Schlegel PM, et al 
Rofo. 2007 Nov 16;
Abstract
 
Utility of brain biopsy in patients with acquired immunodeficiency syndrome before and after
introduction of highly active antiretroviral therapy.
Rosenow JM, Hirschfeld A.  
Neurosurgery. 2007 Jul;61(1):130-40;
Abstract
 
Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients.
Yaldizli O, Kastrup O, Obermann M, et al 
Neurol. 2006 Sep 21
 Abstract
 
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS.
Thompson PM, Dutton RA, Hayashi KM, et al 
Neuroimage. 2006 Jan 18;
Abstract

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex
using a new computerised cognitive test battery.
Cysique LA, Maruff P, Darby D, Brew BJ.  
Arch Clin Neuropsychol. 2005 Dec 9;
Abstract
Brain Abscesses
 

           Journal Papers, Abstracts, and Commentaries

 
Brain abscess: clinical experience and analysis of prognostic factors.
Xiao F, Tseng MY, Teng LJ, Tseng HM, Tsai JC. 
Surg Neurol. 2005 May;63(5):442-9.
 Abstract
 
Mesencephalic cryptococcal abscesses presenting with parkinsonism as an initial
manifestation of AIDS.
Bouffard JP, Mena H, Ripple M, Troncoso J.
Mov Disord. 2003 Nov;18(11):1354-7.
 Abstract

Multiple brain abscesses caused by Fusobacterium nucleatum treated conservatively.
Heckmann JG, Lang CJ, Hartl H, Tomandl B.
Can J Neurol Sci. 2003 Aug;30(3):266-8.
Abstract
Brain Atrophy
           Journal Papers, Abstracts, and Commentaries
 
  Early brain atrophy in HIV infection: a radiological-stereological study.
Korbo L, Praestholm J, Skot J.
Neuroradiology 2002 Apr;44(4):308-313
 Abstract
Brain Lesions
       

     Journal Papers, Abstracts, and Commentaries

 
Seizures in HIV-seropositive individuals: NIMHANS experience and review.
 Satishchandra P, Sinha S.
Epilepsia. 2008 Aug;49 Suppl
Abstract
 
An algorithmic approach to intracranial mass lesions in HIV/AIDS.
Smego RA Jr, Orlovic D, Wadula J.
Int J STD AIDS. 2006 Apr;17(4):271-6.
 Abstract

Management of HIV-associated focal brain lesions in developing countries.
Modi M, Mochan A, Modi G.et al 
QJM. 2004 Jul;97(7):413-421.
 Abstract
Brain Lymphoma
       

     Journal Papers, Abstracts, and Commentaries

 
Highly active antiretroviral therapy and human immunodeficiency virus-associated primary
cerebral lymphoma.
Bower M, Powles T, Nelson M, et al 
Natl Cancer Inst. 2006 Aug 2;98(15):1088-91
 Abstract

Physiopathogenic aspects of HIV-associated primary brain lymphomas.
Camilleri-Broet S, Raphael M.
Rev Neurol (Paris). 2006 Jan;162(1):57-61.
 Abstract
 
Severe HIV-1 Encephalitis and Development of Cerebral Non-Hodgkin Lymphoma in a Patient
with Persistent Strong HIV-1 Replication in the Brain despite Potent HAART - Case Report and
Review of the Literature.
 Baeuerle M, Schmitt-Haendle M, et al 
Eur J Med Res. 2005 Jul 29;10(7):309-16.
 Abstract
 

          Conference Reports, Abstracts, and Posters
 
  The influence of HAART on HIV-associated primary cerebral lymphoma
Goode C., Stebbing J., Mazhar D
(XVI  International AIDS Conference
Abstract
Cognitive Function/Impairment
       
           Journal Papers, Abstracts, and Commentaries
 
 
HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
Ances BM, Clifford DB.
 Curr Neurol Neurosci Rep. 2008 Nov;8(6):455-61.
 Abstract
 
Effects of antiretroviral therapy on cognitive impairment.
 Liner Ii KJ, Hall CD, Robertson KR.  
Curr HIV/AIDS Rep. 2008 May;5(2):64-71
 Abstract

Voltage-gated Potassium Channels in Human Immunodeficiency Virus Type-1 (HIV-1)-associated
Neurocognitive Disorders.
Keblesh J, Hu D, Xiong H.
J Neuroimmune Pharmacol. 2008 May 6
Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment:
Open-Label Reportof ACTG 5090.
Evans SR, Yeh TM, Sacktor N, et al 
HIV Clin Trials. 2007 Nov-Dec;8(6):437-46.
 Abstract
 
FULL TEXT PDF ARTICLE
 Pattern of neuropsychological performance among HIV positive patients in Uganda.
Robertson KR, Nakasujja N, Wong M, et al 
BMC Neurol. 2007 Apr 5;7(1):8
 Paper
 
Cognitive slowing in asymptomatic individuals who are seropositive for human
immunodeficiency virus type 1.
Amador F, Mayor-Rios J, Del Castillo-Martin N.
Rev Neurol. 2006 Feb 1-15;42(3):132-6.
 Abstract
 
Prevalence and risk factors for human immunodeficiency virus-associated
neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort.
Tozzi V, Balestra P, Lorenzini P, et al    
J Neurovirol. 2005 Jul;11(3):265-73.
 Abstract
 
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.
Letendre SL, McCutchan JA, Childers ME, et al
Ann Neurol. 2004 Sep;56(3):416-423.
Abstract
 
ERPs differ from neurometric tests in assessing HIV-associated cognitive deficit.
Tartar JL, Sheehan CM, Nash AJ,et al 
Neuroreport. 2004 Jul 19;15(10):1675-1678.
 Abstract
 
Highly active antiretroviral therapy improves neurocognitive functioning.
Robertson KR, Robertson WT, Ford S, et al
J Acquir Immune Defic Syndr. 2004 Apr 15;36(1):562-6.
Abstract

The Effect of Previous Alcohol Abuse on Cognitive Function in HIV Infection.
Green JE, Saveanu RV, Bornstein RA. 
Am J Psychiatry. 2004 Feb;161(2):249-54.
Abstract

Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early
After HIV Seroconversion.
Marcotte TD, Deutsch R, McCutchan JA, et al.
 Abstract
 
Neurocognitive Function in HIV-Infected Patients With Low Weight and Weight Loss.
Dolan S, Montagno A, Wilkie S, et al >
J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):155-64.
Abstract

The role of cognitive impairment in desire for hastened death: a study of patients with
advanced AIDS.
Pessin H, Rosenfeld B, Burton L, Breitbart W .
Gen Hosp Psychiatry 2003 May-Jun;25(3):194-9
 Abstract
 

  
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.
Cherner M, Masliah E, Ellis RJ,et al.
Neurology 2002 Nov 26;59(10):1563-7
 Abstract
 
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
Clifford DB, McArthur JC, Schifitto G, et al
Neurology 2002 Nov 26;59(10):1568-73
 Abstract
 
Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the
NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study.
Starace F, Bartoli L, Aloisi MS, et al
Acta Psychiatr Scand 2002 Jul;106(1):20-6
 Abstract
 
  Relationships between cognition and structural neuroimaging findings in adults with human i
mmunodeficiency virus type-1.
Paul R, Cohen R, Navia B, Tashima K.
Neurosci Biobehav Rev 2002 May;26(3):353-9
 Abstract
 
  Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment.
Marder K, Albert SM, McDermott MP, et al.
Neurology 2003 May 13;60(9):1467-1473
 Abstract
 
  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.
De Ronchi D, Faranca I, Berardi D, et al.
Arch Neurol 2002 May;59(5):812-8
 Abstract
 
  HIV-associated cognitive impairment before and after the advent of combination
therapy.
Sacktor N, McDermott MP, Marder K, et al.
J Neurovirol 2002 Apr;8(2):136-42
 Abstract

          Conference Reports, Abstracts, and Posters

 
CEP-1347 as an Adjunctive Therapy for HIV-associated Cognitive Impairment
D Egger,t S Gorantla, H Dou, et al
(15 CROI )
 Abstract
 
Adverse Effect of ddI, ddC and d4T as a Component of  HAART on Cognitive Function
during HIV Infection
I Husstedt, B Hudelmeier, U Oelker-Gruneberg, et al
Abstract
 
A Phase II, Placebo-controlled, Double-blind Study of the Selegiline Transdermal System in the
Treatment of HIV-associated Cognitive Impairment
G Schifitto, N Sacktor, J Zhang, et al 
(13 CROI )
 Abstract
 
POSTER
Improved Cognitive Function in Immune Reconstituted Advanced AIDS Patients Is
Associated with Maintenance of HIV Suppression
A McCutchan. J Wu, P Williams, et al
 (11 CROI)
 PDF Poster    Abstract
 
POSTER
 Neuroocognitive Impairment and Survival in HIV-Positive Patients Treated with HAART:
Results from an Urban Observational Cohort
V Tozzi, P Balestra, D Serraino, et al
 (11 CROI)
 PDF Poster    Abstract
 
Perception Disorders
 

           Journal Papers, Abstracts, and Commentaries

  Perceptual span deficits in adults with HIV.
Hardy DJ, Castellon SA, Hinkin CH.
 J Int Neuropsychol Soc. 2004 Jan;10(1):135-40.
Abstract
Encephalopathy
       
           Journal Papers, Abstracts, and Commentaries
 
 
Clinical features and courses of 5 cases with HIV encephalopathy
Hashimoto R, Mukai E, Yokomaku Y, et al 
Rinsho Shinkeigaku. 2008 Mar;48(3):173-8.
Abstract
 
A patient with HIV encephalopathy presenting with parkinsonism during HAART therapy
Shimohata T, Takadou Y, Terajima K, et al 
No To Shinkei. 2006 Jun;58(6):495-9.
 Abstract
 
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune
restoration in AIDS-related progressive multifocal leukoencephalopathy.
 Vendrely A, Bienvenu B, Gasnault J, et al
Acta Neuropathol (Berl). 2005 Mar 1;
Abstract

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy
in the era of highly active antiretroviral therapy.
Neuenburg JK, Brodt HR, Herndier BG, et al.  
J Acquir Immune Defic Syndr 2002 Oct 1;31(2):171-7
 Abstract

 

          Conference Reports, Abstracts, and Posters

  POSTER
 Potentially Preventive Effect of Didanosine against HIV Encephalopathy
I Poizot Martin, M P Milon, M P Drogoul, et al  1
(11 CROI)
PDF Poster    Abstract  
Encephalitis
       
           Journal Papers, Abstracts, and Commentaries
 
 
Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium
subjects with HIV encephalitis.
Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM.
J Neuroimmune Pharmacol. 2006 Dec;1(4):410-20.
Abstract
 
Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy.]
Trocello JM, Blanchet A, Bourdain F, et al  
Rev Neurol (Paris). 2006 Jan;162(1):89-91
 Abstract
 
The shifting patterns of HIV encephalitis neuropathology.
Everall IP, Hansen LA, Masliah E.
Neurotox Res. 2005 Oct;8(1,2):51-62.
 Abstract
 
Subacute uveomeningoencephalitis as the presenting symptom of acute infection by
the human immunodeficiency virus.
Pascual-Lozano AM, Salvador-Aliaga A, Coret-Ferrer F, Lainez-Andres JM.
Rev Neurol. 2005 Sep 1-15;41(5):273-6.
 Abstract
 
Severe HIV-1 Encephalitis and Development of Cerebral Non-Hodgkin Lymphoma in a Patient
with Persistent Strong HIV-1 Replication in the Brain despite Potent HAART - Case Report and
Review of the Literature.
 Baeuerle M, Schmitt-Haendle M, et al 
Eur J Med Res. 2005 Jul 29;10(7):309-16.
 Abstract

HIV encephalitis simulating Huntington's disease.
Sevigny JJ, Chin SS, Milewski Y, et al
Mov Disord. 2005 Feb 9;
Abstract

 

          Conference Reports, Abstracts, and Posters

  Cytomegalovirus (CMV) encephalitis in a patient with advanced HIV after initiation of
highly active antiretroviral therapy (HAART)
 W Tantisiriwat, C Ruangkit, S Reepolmaha, et al
 (15IAC)
 Abstract
Cerebral Histoplasmosis    
Histoplasmosis      

        Journal Papers, Abstracts, and Commentaries  

  A case of HIV-associated cerebral histoplasmosis successfully treated with
fluconazole.
Knapp S, Turnherr M, Dekan G, Willinger B , et al.  
Eur J Clin Microbiol Infect Dis 1999 Sep;18(9):658-61
Abstract
Cerebral Toxoplasmosis        
Toxoplasmosis        

          Journal Papers, Abstracts, and Commentaries

 
Severe Toxoplasma gondii I/III recombinant genotype encephalitis in a HIV patient.
Genot S, Franck J, Forel JM, et al  
J Clin Microbiol. 2007 Jul 18;
Abstract

 HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis
in a 45-year-old man.
Murata M, Furusyo N, Otaguro S,
J Infect Chemother. 2007 Feb;13(1):51-5
 Abstract
 
Cerebral Toxoplasmosis in HIV-Positive Patients in Brazil: Clinical Features and Predictors
of Treatment Response in the HAART Era.
Vidal JE, Hernandez AV, Oliveira AC, Dauar RF, et al
AIDS Patient Care STDS. 2005 Oct;19(10):840-8.
Abstract
 
Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic
encephalitis in patients with advanced HIV infection during HAART.
Langmann P, Schirmer D, Zilly M, Klinker H.  
Med Sci Monit. 2004 May;10(5):PI65-9.
Abstract

Cerebral Toxoplasmosis.
Nath A, Sinai AP.
Curr Treat Options Neurol 2003 Jan;5(1):3-12
 Abstract
   
  Host resistance in the brain against Toxoplasma gondii.
Suzuki Y.
J  Infect Dis 2002 Feb 15;185 Suppl 1:S58-65
Abstract
   
  Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium
complex infection and toxoplasmic encephalitis.
Zeller V, Truffot C, Agher R, et al.
Clin Infect Dis 2002 Mar 1;34(5):662-7
Abstract
   
  Case report. Toxoplasma encephalitis after initiation of HAART.
Tsambiras PE, Larkin JA, Houston SH.
AIDS Read 2001 Dec;11(12):608-10, 615-6
 Abstract
   
  Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment
of toxoplasmic encephalitis in AIDS.
Jacobson JM, Hafner R, Remington J, et al.
AIDS 2001 Mar 30;15(5):583-9
 Abstract
   
  HIV-2 infection with cerebral toxoplasmosis and lymphomatoid granulomatosis.
Issakhanian M, Chang L, Cornford M et al.
J Neuroimaging 2001 Apr;11(2):212-6
 Abstract
   
  Cerebral toxoplasmosis in HIV- infected patients intolerant of cotrimoxazole.
Rabaud C, May T, Beuscart C, Reynes J, et al.
Ann Med Interne (Paris) 1998 Mar;149(2):62-6
 Abstract
   
  Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii
pneumonia  relapse and toxoplasmic encephalitis in patients with AIDS.
Schurmann D, Bergmann F, Albrecht H, et al.
J Infect 2001 Jan;42(1):8-15
 Abstract
   
  Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy.
Luft BJ, Chua A.
Curr Infect Dis Rep 2000 Aug;2(4):358-362
 Abstract
Cerebral Lymphocytosis
       

        Journal Papers, Abstracts, and Commentaries  
  Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration
induced by HAART.
Miller RF, Isaacson PG, Hall-Craggs M,et al.  
Acta Neuropathol (Berl). 2004 Apr 14
 Abstract
Leukoencephalopathy
Progressive Multifocal Leukoencephalopathy      

        Journal Papers, Abstracts, and Commentaries  
 
Reversible Posterior Leukoencephalopathy Syndrome in 2 HIV-Infected Patients Receiving
Antiretroviral Therapy.
Ridolfo AL, Resta F, Milazzo L, et al 
Clin Infect Dis. 2008 Jan 15;46(2):e19-22.
 Abstract

Convalescence of atypical reversible posterior leukoencephalopathy syndrome
in human immunodeficiency virus infection.
Tanioka R, Yamamoto Y, Sakai M, et al 
J Med Invest. 2007 Feb;54(1-2):191-4
 Abstract
Memory Disorders
       

        Journal Papers, Abstracts, and Commentaries  
  Frequency and predictors of self-reported prospective memory complaints in individuals
infected with HIV.
Woods SP, Carey CL, Moran LM 
Arch Clin Neuropsychol. 2007 Feb 5
 Abstract
 
Prospective memory in HIV-1 infection.
Carey CL, Woods SP, Rippeth JD, Heaton RK
J Clin Exp Neuropsychol. 2006 May;28(4):536-48.
 Abstract
 
Memory loss in persons with HIV/AIDS: assessment and strategies for coping.
Selnes OA.
AIDS Read. 2005 Jun;15(6):289-92, 294
 Abstract
Movement/Motor Disorders
       
           Journal Papers, Abstracts, and Commentaries
 
 
Upper and Lower Limb Motor Impairments in Alcoholism, HIV Infection, and Their Comorbidity.
Fama R, Eisen JC, Rosenbloom MJ, Sassoon SA, et al
Alcohol Clin Exp Res. 2007 Mar 31;
 Abstract

Human Immunodeficiency Virus 1-associated Minor Motor Disorders:Perfusion-
weighted MR Imaging and H MR Spectroscopy.
Wenserski F, Von Giesen HJ
Radiology 2003 May 20
 Abstract

  
     
  Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction.
Clay PG, Adams MM.
Ann Pharmacother 2003 Feb;37(2):202-5
 Abstract		  
     
  Movement disorders in 28 HIV-infected patients.
Mattos JP, Rosso AL, Correa RB, Novis SA.
Arq Neuropsiquiatr 2002 Sep;60(3-A):525-30
 Abstract		  
     
  HIV-related movement disorders: epidemiology, pathogenesis and management.
Cardoso F.
CNS Drugs 2002;16(10):663-8
 Abstract		  
     
  Parkinsonism in HIV dementia.
Koutsilieri E, Sopper S, Scheller C, et al
J Neural Transm 2002 May;109(5-6):767-75
 Abstract		  
     
  Potential time course of human immunodeficiency virus type 1-associated minor motor
deficits: electrophysiologic and positron emission tomography findings.
von Giesen HJ, Antke C, Hefter H, et al
Arch Neurol 2000 Nov;57(11):1601-7
 Abstract		  
     
  Hemichorea-hemiballism associated to cryptococcal granuloma in a patient with AIDS:
case report
Teive HA, Troiano AR, Cabral NL, et al
Arq Neuropsiquiatr 2000 Sep;58(3B):965-8
 Abstract		  
Seizures/Epilepsy
       

     Journal Papers, Abstracts, and Commentaries